In vitro and ex vivo investigation of the impact of luminal lipid phases on passive permeability of lipophilic small molecules using PAMPA

Pharm Res. 2013 Dec;30(12):3145-53. doi: 10.1007/s11095-013-1141-1. Epub 2013 Jul 27.

Abstract

Purpose: Evaluate the impact of luminal micellar phase on passive permeability of five lipophilic (1.9 ≤ clogP ≤ 9.0) small molecules using biorelevant media and evaluate the impact of luminal coarse lipid particles on danazol permeability after oral administration of a triglyceride solution to fed adults using PAMPA.

Methods: Permeability of carbamazepine, furosemide, danazol, and Compound A was evaluated using Prisma™ HT, FaSSIF-V2, and FeSSIF-V2 in the donor compartment. Compound B could not be tested using Prisma™ HT, due to negligible solubility. Individual intestinal aspirates collected after administration of danazol solution in the olive oil portion of a meal and corresponding micellar phases were subjected to PAMPA. Commercially available Acceptor Sink Buffer was used in all cases.

Results: Unlike with furosemide (under constant pH) and Compound B, permeability of carbamazepine, danazol, and Compound A steadily decreased in the presence of increasing micelle concentration of media. Danazol permeability from aspirates was reduced compared to that from micellar phases; fluxes were similar.

Conclusions: Using PAMPA, the impact of luminal micellar phase on passive permeability of lipophilic molecules varies with the molecule. After administration of a triglyceride solution of danazol, high danazol concentrations in coarse lipid particles balance in terms of drug flux the reduced permeability.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Adult
  • Danazol / administration & dosage
  • Danazol / pharmacokinetics*
  • Estrogen Antagonists / administration & dosage
  • Estrogen Antagonists / pharmacokinetics*
  • Humans
  • Intestinal Absorption
  • Micelles*
  • Permeability
  • Pharmaceutical Vehicles / chemistry*
  • Solubility
  • Triglycerides / chemistry*

Substances

  • Estrogen Antagonists
  • Micelles
  • Pharmaceutical Vehicles
  • Triglycerides
  • Danazol